Role of coagulation factor Xa and protease-activated receptor 2 in human mesangial cell proliferation

Kidney International

Volumn 67, Issue 6, 2005, Pages 2123-2134

  Tanaka, Misa ^b   Arai, Hidenori ^b   Liu, Ning ^b   Nogaki, Fumiaki ^b   Nomura, Keiko ^b   Kasuno, Kenji ^b   Oida, Emi ^b   Kita, Toru ^b   Ono, Takahiko ^a  

^a UNIVERSITY OF SHIZUOKA   (Japan)

^b NONE

Author keywords

Coagulation; Factor Xa inhibitor; PAR2; Proliferation

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 [4 [(1 ACETIMIDOYL 3 PYRROLIDINYL)OXY]PHENYL] 3 (7 AMIDINO 2 NAPHTHYL)PROPIONIC ACID; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; BLOOD CLOTTING FACTOR 10A; FIBRIN; FR 171113; MITOGEN ACTIVATED PROTEIN KINASE; PROTEINASE ACTIVATED RECEPTOR 2; THYMIDINE; UNCLASSIFIED DRUG; BENZAMIDE DERIVATIVE; NAPHTHALENE DERIVATIVE; PROPIONIC ACID DERIVATIVE; PROTEINASE ACTIVATED RECEPTOR 1; THIAZOLE DERIVATIVE; THIAZOLIDINE DERIVATIVE;

ARTICLE; BLOOD CLOTTING; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG INHIBITION; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME INHIBITION; FIBRIN DEPOSITION; HUMAN; HUMAN CELL; MESANGIUM CELL; PRIORITY JOURNAL; CYTOLOGY; MESANGIUM; PHYSIOLOGY;

BENZAMIDES; CELL PROLIFERATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FACTOR XA; GLOMERULAR MESANGIUM; HUMANS; NAPHTHALENES; PROPIONIC ACIDS; RECEPTOR, PAR-1; RECEPTOR, PAR-2; THIAZOLES; THIAZOLIDINES;

EID: 23044510603     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.00317.x     Document Type: Article

References (53)

1. KINCAID-SMITH P: Coagulation and renal disease. Kidney Int 2:183-190, 1972
2. TAKEMURA T, YOSHIOKA K, AKANO N, et al: Glomerular deposition of cross-linked fibrin in human kidney diseases. Kidney Int 32:102-111, 1987
3. ONO T, MUSO E, SUYAMA K, et al: Intraglomerular deposition of intact cross-linked fibrin in IgA nephropathy and Henoch-Schönlein purpura nephritis. Nephron 74:522-528, 1996
4. ONO T, LIU N, KASUNO K, et al: Coagulation process proceeds on cultured human mesangial cells via expression of factor V. Kidney Int 60:1009-1017, 2001
5. MONNO R, GRANDALIANO G, FACCIO R, et al: Activated coagulation factor X: A novel mitogenic stimulus for human mesangial cells. J Am Soc Nephrol 12:891-899, 2001
6. MACFARLANE SR, SEATTER MJ, KANKE T, et al: Proteinase-activated receptors. Pharmacol Rev 53:245-282, 2001
7. OSSOVSKAYA VS, BUNNETT NW: Protease-activated receptors: Contribution to physiology and disease. Physiol Rev 84:579-621, 2004
8. GRAND RJ, TURNELL AS, GRABHAM PW: Cellular consequences of thrombin-receptor activation. Biochem J 313:353-368, 1996
9. COUGHLIN SR: Thrombin signalling and protease-activated receptors. Nature 407:258-264, 2000
10. DUGINA TN, KISELEVA EV, CHISTOV IV, et al: Receptors of the PAR family as a link between blood coagulation and inflammation. Biochemistry (Mosc) 67:65-74, 2002
11. VU TK, HUNG DT, WHEATON VI, COUGHLIN SR: Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64:1057-1068, 1991
12. MARI B, GUERIN S, FAR DF, et al: Thrombin and trypsin-induced Ca (2+) mobilization in human T cell lines through interaction with different protease-activated receptors. FASEB J 10:309-316, 1996
13. ISHIHARA H, CONNOLLY AJ, ZENG D, et al: Protease-activated receptor 3 is a second thrombin receptor in humans. Nature 386:502-506, 1997
14. XU WF, ANDERSEN H, WHITMORE TE, et al: Cloning and characterization of human protease-activated receptor 4. Proc Natl Acad Sci USA 95:6642-6646, 1998
15. BONO F, SCHAEFFER P, HERAULT JP, et al: Factor Xa activates endothelial cells by a receptor cascade between EPR-1 and PAR-2. Arterioscler Thromb Vasc Biol 20:E107-E112, 2000
16. RIEWALD M, RUF W: Mechanistic coupling of protease signaling and initiation of coagulation by tissue factor. Proc Natl Acad Sci USA 98:7742-7747, 2001
17. SHIMIZU T, NISHIHIRA J, WATANABE H, et al: Macrophage migration inhibitory factor is induced by thrombin and factor Xa in endothelial cells. J Biol Chem 279:13729-13737, 2004
18. NAGAHARA T, YOKOYAMA Y, INAMURA K, et al: Dibasic (amidinoaryl) propanoic acid derivatives as novel blood coagulation factor Xa inhibitors. J Med Chem 37:1200-1207, 1994
19. HARA T, YOKOYAMA A, ISHIHARA H, et al: DX-9065a, a new synthetic, potent anticoagulant and selective inhibitor for factor Xa. Thromb Haemost 71:314-319, 1994
20. BRETSCHNEIDER E, BRAUN M, FISCHER A, et al: Factor Xa acts as a PDGF-independent mitogen in human vascular smooth muscle cells. Thromb Haemost 84:499-505, 2000
21. HERAULT JP, BONO F, AVRIL C, et al: Activation of human vascular endothelial cells by factor Xa: Effect of specific inhibitors. Biochem Pharmacol 57:603-610, 1999
22. YAMAZAKI M, ASAKURA H, AOSHIMA K, et al: Effects of DX-9065a, an orally active, newly synthesized and specific inhibitor of factor Xa, against experimental disseminated intravascular coagulation in rats. Thromb Haemost 72:392-396, 1994
23. HARA T, YOKOYAMA A, MORISHIMA Y, KUNITADA S: Species differences in anticoagulant and anti-Xa activity of DX-9065a, a highly selective factor Xa inhibitor. Thromb Res 80:99-104, 1995
24. YAMAZAKI M, ASAKURA H, AOSHIMA K, et al: Protective effects of DX-9065a, an orally active, novel synthesized and selective inhibitor of factor Xa, against thromboplastin-induced experimental disseminated intravascular coagulation in rats. Semin Thromb Hemost 22:255-259, 1996
25. HERBERT JM, BERNAT A, DOL F, et al: DX 9065 A a novel, synthetic, selective and orally active inhibitor of factor Xa: In vitro and in vivo studies. J Pharmacol Exp Ther 276:1030-1038, 1996
26. HERAULT JP, BERNAT A, PFLIEGER AM, et al: Comparative effects of two direct and indirect factor Xa inhibitors on free and clot-bound prothrombinase. J Pharmacol Exp Ther 283:16-22, 1997
27. KATO Y, KITA Y, NISHIO M, et al: In vitro antiplatelet profile of FR171113, a novel non-peptide thrombin receptor antagonist. Eur J Pharmacol 384:197-202, 1999
28. KATO Y, KITA Y, HIRASAWA-TANIYAMA Y, et al: Inhibition of arterial thrombosis by a protease-activated receptor 1 antagonist, FR171113, in the guinea pig. Eur J Pharmacol 473:163-169, 2003
29. VILA V, RAGANON E, LLOPIS F, AZNAR J: Isolation of human fibrinogen using nitroblue tetrazolium (NBT). Clin Chim Acta 138:215-219, 1984
30. ONO T, KANATSU K, DOI T, et al: Immunoelectron microscopic localization of fibrin-related antigen in human glomerular diseases. Nephron 52:238-243, 1989
31. SCHMIDLIN F, AMADESI S, VIDIL R, et al: Expression and function of proteinase-activated receptor 2 in human bronchial smooth muscle. Am J Respir Crit Care Med 164:1276-1281, 2001
32. OOMURA A, NAKAMURA T, ARAKAWA M, et al: Alterations in the extracellular matrix components in human glomerular diseases. Virchows Arch A Pathol Anat Histopathol 415:151-159, 1989
33. LIU N, MAKINO T, NOGAKI F, et al: Coagulation in the mesangial area promotes ECM accumulation through factor V expression in MsPGN in rats. Am J Physiol Renal Physiol 287:F612-F620, 2004
34. TIPPING PG, DOWLING JP, HOLDSWORTH SR: Glomerular procoagulant activity in human proliferative glomerulonephritis. J Clin Invest 81:119-125, 1988
35. CUNNINGHAM MA, ONO T, HEWITSON TD, et al: Tissue factor pathway inhibitor expression in human crescentic glomerulonephritis. Kidney Int 55:1311-1318, 1999
36. ONO T, LIU N, MAKINO T, et al: Role of mesangial factor V expression in crescent formation in rat experimental mesangioproliferative glomerulonephritis. J Pathol 204:229-238, 2004
37. BOKEMEYER D, SOROKIN A, DUNN MJ: Multiple intracellular MAP kinase signaling cascades. Kidney Int 49:1187-1198, 1996
38. BOKEMEYER D, PANEK D, KRAMER HJ, et al: In vivo identification of the mitogen-activated protein kinase cascade as a central pathogenic pathway in experimental mesangioproliferative glomerulonephritis. J Am Soc Nephrol 13:1473-1480, 2002
39. BONO F, HERAULT JP, AVRIL C, et al: Human umbilical vein endothelial cells express high affinity receptors for factor Xa. J Cell Physiol 172:36-43, 1997
40. BLANC-BRUDE OP, CHAMBERS RC, LEONI P, et al: Factor Xa is a fibroblast mitogen via binding to effector-cell protease receptor-1 and autocrine release of PDGF. Am J Physiol Cell Physiol 281:C681-C689, 2001
41. GASIC GP, ARENAS CP, GASIC TB, GASIC GJ: Coagulation factors X, Xa, and protein S as potent mitogens of cultured aortic smooth muscle cells. Proc Natl Acad Sci USA 89:2317-2320, 1992
42. Ko FN, YANG YC, HUANG SC, OU JT: Coagulation factor Xa stimulates platelet-derived growth factor release and mitogenesis in cultured vascular smooth muscle cells of rat. J Clin Invest 98:1493-1501, 1996
43. HERBERT J, BONO F, HERAULT J, et al: Effector protease receptor 1 mediates the mitogenic activity of factor Xa for vascular smooth muscle cells in vitro and in vivo. J Clin Invest 101:993-1000, 1998
44. KOO BH, CHUNG KH, HWANG KC, KIM DS: Factor Xa induces mitogenesis of coronary artery smooth muscle cell via activation of PAR-2. FEBS Lett 523:85-89, 2002
45. KOO BH, KIM DS: Factor Xa induces mitogenesis of vascular smooth muscle cells via autocrine production of epiregulin. J Biol Chem 278:52578-52586, 2003
46. EISENBERG PR, SIEGEL JE, ABENDSCHEIN DR, MILETICH JP: Importance of factor Xa in determining the procoagulant activity of whole-blood clots. J Clin Invest 91:1877-1883, 1993
47. IINO M, TAKEYA H, TAKEMITSU T, et al: Characterization of the binding of factor Xa to fibrinogen/fibrin derivatives and localization of the factor Xa binding site on fibrinogen. Eur J Biochem 232:90-97, 1995
48. HERTIG A, RONDEAU E: Role of the coagulation/fibrinolysis system in fibrin-associated glomerular injury. J Am Soc Nephrol 15:844-853, 2004
49. CHAMBERS LS, BLACK JL, PORONNIK P, JOHNSON PR: Functional effects of protease-activated receptor-2 stimulation on human airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 281:L1369-L1378, 2001
50. O'BRIEN PJ, KOI H, PARRY S, et al: Thrombin receptors and protease-activated receptor-2 in human placentation: Receptor activation mediates extravillous trophoblast invasion in vitro. Am J Pathol 163:1245-1254, 2003
51. CUNNINGHAM MA, RONDEAU E, CHEN X, et al: Protease-activated receptor 1 mediates thrombin-dependent, cell-mediated renal inflammation in crescentic glomerulonephritis. J Exp Med 191:455-462, 2000
52. LINDNER JR, KAHN ML, COUGHLIN SR, et al: Delayed onset of inflammation in protease-activated receptor-2-deficient mice. J Immunol 165:6504-6510, 2000
53. KAHN ML, HAMMES SR, BOTKA C, COUGHLIN SR: Gene and locus structure and chromosomal localization of the protease-activated receptor gene family. J Biol Chem 273:23290-23296, 1998